Retinal Degeneration 3 (RD3) Peptide
RD3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN938889
Quick Overview for Retinal Degeneration 3 (RD3) Peptide (ABIN938889)
Target
RD3
(Retinal Degeneration 3 (RD3))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- GQMREAERQQ RERSNAVRKV CTGVDYSWLA STPRSTYDLS PIERLQLEDV
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RD3 antibody,
Alternative Names: RD3 control peptide, RD3 antibody Blocking Peptide, Anti-RD3 Blocking Peptide, Retinal Degeneration 3 Blocking Peptide, C1orf36 Blocking Peptide, LCA12 Blocking Peptide, RD3, RD-3, RD 3, RD-3 Blocking Peptide, RD 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- RD3 (Retinal Degeneration 3 (RD3))
-
Background
- RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
-
Molecular Weight
- 23 kDa
Target
-
You are here:
